Form 8-K - Current report:
SEC Accession No. 0000950170-25-024989
Filing Date
2025-02-21
Accepted
2025-02-21 17:25:09
Documents
13
Period of Report
2025-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250220.htm   iXBRL 8-K 53109
2 EX-10.1 hcwb-ex10_1.htm EX-10.1 346804
3 EX-10.2 hcwb-ex10_2.htm EX-10.2 178359
  Complete submission text file 0000950170-25-024989.txt   774513

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250220.xsd EX-101.SCH 24849
15 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250220_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 25653315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)